In April 2020, the ‘Chief Scientific Advisor’ to the UK Government – Sir Patrick Vallance was placed in charge of the new ‘Vaccine Taskforce’. The aim of this taskforce was to “drive forward, expedite and co-ordinate efforts to research and then produce a coronavirus vaccine.”
So isn’t it interesting how by July 2020 the UK Government signed a contract with GlaxoSmithKline to secure 60 million doses of an untested, experimental “vaccine” treatment that was still being developed to combat SARS-CoV-2? Interesting because the chief scientific advisor and head of the ‘Vaccine Taskforce’ has £600,000 worth of shares in the pharmaceutical giant, GlaxoSmithKline.
Sir Patrick, who has had huge influence in dictating the Government’s response to the alleged SARS-CoV-2 pandemic, has over 43,111 shares in the company. But the conflict of interest doesn’t end there. Sir Patrick Vallance used to be the president of GlaxoSmithKline.
He joined the company in May 2006 as ‘Head of Drug Discovery’, going on to become Senior Vice President of Medicines Discovery and Development, before finally becoming President in 2006.
When the pompous Health Secretary, Matt Hancock found out about this he said “Well, I didn’t know about it until I read it in the newspapers,”. Pushed on whether he thought he should have been informed as Health Secretary, he replied: “No, not particularly”.
Just recently, the Deputy Chief Medical Officer for England – Jonathan Van Tam said that it was “perfectly possible” a “Covid” vaccine could be licensed for children by the end of the year. Stating that he believes “most of the major manufacturers are beginning to turn their attention “to licensing vaccines for under-18’s”.
But we’ve been repeatedly told that children are at no risk to the Covid-19 disease, so why on earth do we need to vaccinate them?
Well Professor Van Tam’s career history can possibly clarify why he is so eager to see children vaccinated against a disease they supposedly don’t suffer from.
Van Tam joined the pharmaceutical industry in 1997 as an associate director at SmithKline Beecham. He then went on to become Head of Medical Affairs at Roche in April 2001, before joining Aventis Pasteur MSD in February 2002 as the UK medical director.
In 2010 he became an advisor to the World Health Organisation, during the over exaggerated H5N1 influenza pandemic. His advice was to roll out a mass vaccination programme to combat the H5N1 influenza virus, and that advice was followed. But guess who manufactured the H5N1 influenza vaccines and made billions of pounds? SmithKline Beecham and Roche, two pharmaceutical giants that Van Tam worked for.